Outlook on the Software as a Medical Device Global Market to 2029 - Featuring Qlarity Imaging, Arterys, Apple and IDx Technologies Among Others - ResearchAndMarkets.com

Diagnostic Reagents
DUBLIN--(BUSINESS WIRE)--The "Software as a Medical Device Market Analysis by Device (Smartphone, Desktop/Laptop, Wearable Devices), by Deployment (On-premise, Cloud-based), by Application (Clinical Management, Diagnostic), and by Region - Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
'Software as a Medical Device Market Analysis by Device (Smartphone, Desktop/Laptop, Wearable Devices), by Deployment (On-premise, Cloud-based), by Application (Clinical Management, Diagnostic), and by Region - Forecast to 2029'
The global software as a medical device (SaMD) market size is estimated to be USD 847.5 million in 2021 and is expected to witness a CAGR of 86.91% during the forecast period.
Companies Mentioned
Apple Inc. (U.S.)
MaxQ AI (U.S.)
Siemens AG (Germany)
Increasing application of artificial intelligence in diagnostic of chronic illness is a key driver for the growth of the global software as a medical device market. Additionally, the rising geriatric population, growing demand for cost-effective quality healthcare services, and government support for the treatment of chronic diseases are some of the other drivers propelling the market growth.
However, the ambulatory regulatory policies and lack of awareness for technology are expected to restrain the global market growth.
Software As A Medical Device Market, By Device (Revenue, USD Million, 2021 - 2029)
Smartphone
Desktop/Laptop
Wearable Devices
Software As A Medical Device Market, By Deployment (Revenue, USD Million, 2021 - 2029)
On-premise
Cloud-based
Software As A Medical Device Market, By Application (Revenue, USD Million, 2021 - 2029)
Diagnostic
Software As A Medical Device Market, By Region (Revenue, USD Million, 2021 - 2029)
North America
U.S.
Canada
Europe
Germany
France
UK
Spain
Italy
Russia
Rest of Europe
China
Japan
India
Australia
South Korea
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Rest of LATAM
Middle East & Africa
South Africa
Saudi Arabia
Rest of MEA
For more information about this report visit https://www.researchandmarkets.com/r/74zrau
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.